Age-Related Cognitive Decline (ARCD) Support Protocol

Cognitive & Brain HealthModerate Evidence
9
supplements
2
Primary
7
Supporting
0
Grade A
138
Studies

Primary Stack

Core supplements with strongest evidence
400-800mg highly bioavailable curcumin daily (Theracurmin, Meriva, or with piperine)

Anti-inflammatory and neuroprotective; may improve memory and reduce brain amyloid accumulation

CognitionProcessing SpeedExecutive FunctionWorking Memory
12 studies600 participants
1-2g DHA daily (or 2-4g total EPA+DHA with higher DHA)

DHA is essential brain structural component; may slow cognitive decline and support memory

CognitionCognitive Decline
20 studies3,000 participants

Supporting Stack

Additional supplements for enhanced results
120-240mg standardized extract daily (24%/6%)

Improves cerebral blood flow and has antioxidant effects; may help with memory and processing speed

CognitionAttentionCognitive DeclineMemoryReaction Time
25 studies3,000 participants
500-1000mg daily

Supports phospholipid synthesis and acetylcholine production; may improve memory and attention

Blood PressureCognitive DeclineMemory
15 studies1,500 participants
100-300mg daily

Major membrane phospholipid that supports cognitive function and may improve memory in elderly

Blood PressureCognitionCognitive DeclineMemoryHeart Rate
12 studies800 participants
2000-4000 IU daily (based on blood levels)

Deficiency associated with cognitive decline; supplementation may support brain health in elderly

CognitionDepression SymptomsFatigue Symptoms
20 studies4,000 participants
B6 25-50mg, B12 500-1000mcg, Folate 800mcg daily

Reduce homocysteine which damages brain; B12 deficiency causes cognitive impairment

CognitionDepression SymptomsFatigue Symptoms
18 studies3,000 participants
300-600mg standardized extract daily (50% bacosides)

Traditional Ayurvedic herb that supports memory and cognitive function through multiple mechanisms

AttentionMemoryBasophil CountEosinophil countGranulocyte Count
10 studies500 participants
100-300mg extract daily

Traditional Chinese herb that may enhance memory and protect neurons

Cognitive DeclineMemoryVerbal Fluency
6 studies250 participants

How This Protocol Works

Simple Explanation

Age-related cognitive decline is the gradual decrease in mental abilities that occurs as we get older. This is different from dementia—it's the normal 'senior moments' many people experience: taking longer to learn new things, occasionally forgetting names, or feeling like your mind isn't as sharp as it used to be. While some cognitive decline is inevitable with aging, the rate and extent can be influenced by lifestyle factors and nutritional support.

IMPORTANT: Cognitive decline should be evaluated to distinguish normal aging from mild cognitive impairment (MCI) or early dementia. If you notice significant changes in memory or thinking, see a healthcare provider for proper assessment.

Curcumin (from turmeric) has powerful anti-inflammatory and antioxidant effects. Chronic inflammation and oxidative stress contribute to brain aging. A clinical trial showed curcumin improved memory and mood in older adults, and PET scans revealed reduced amyloid (a protein associated with Alzheimer's) in the brain. Use a bioavailable form for best results.
Omega-3 Fatty Acids, particularly DHA, are essential structural components of brain cell membranes. The brain is 60% fat, and much of that is DHA. Higher omega-3 intake is associated with slower cognitive decline and better brain structure on imaging. DHA supports the flexibility of brain cell membranes needed for proper signaling.
Ginkgo Biloba is one of the oldest living tree species and has been used for brain health for centuries. It improves blood flow to the brain and has antioxidant effects. Studies show modest benefits for memory and processing speed in older adults.
CDP-Choline (Citicoline) provides building blocks for brain cell membranes and supports acetylcholine, the neurotransmitter most associated with memory. Studies show it may improve memory, attention, and overall cognitive function in people with age-related decline.
Phosphatidylserine is a component of brain cell membranes that decreases with age. Supplementation may help support cognitive function, particularly memory and attention.
Vitamin D deficiency is extremely common in older adults and is strongly associated with faster cognitive decline. The brain has vitamin D receptors throughout, and the vitamin supports neuronal health and reduces inflammation.
B Vitamins (B6, B12, Folate) reduce homocysteine, an amino acid that at high levels damages the brain. The landmark VITACOG trial showed B vitamins slowed brain shrinkage by 30% in people with elevated homocysteine. B12 deficiency specifically causes cognitive problems that can be reversed with supplementation.
Bacopa Monnieri is an Ayurvedic herb that has been used for centuries to enhance memory. Modern research confirms it improves memory consolidation and recall, with effects building over 8-12 weeks.
Polygala Tenuifolia is a traditional Chinese medicine herb used for memory. Early research suggests it may support cognitive function through multiple mechanisms.

Expected timeline: Curcumin: 4-8 weeks. Omega-3: 8-12 weeks. Ginkgo: 4-8 weeks. B vitamins: 4-12 weeks. Bacopa: 8-12 weeks. Cognitive support is ongoing—these supplements work best with continued use.

Clinical Perspective

Age-associated cognitive decline encompasses the normal age-related changes in processing speed, working memory, and new learning while crystallized intelligence (vocabulary, general knowledge) is preserved. Mild Cognitive Impairment (MCI) represents a transitional state between normal aging and dementia with measurable deficits but preserved daily function. Pathophysiology involves synaptic loss, white matter changes, neuroinflammation, oxidative stress, vascular factors, and protein aggregation (tau, amyloid). Modifiable risk factors: cardiovascular disease, diabetes, depression, sleep apnea, hearing loss, social isolation.

CRITICAL: Cognitive complaints warrant medical evaluation to rule out treatable causes (B12 deficiency, thyroid, depression, sleep apnea, medications) and to assess for MCI/dementia. Supplements may support cognition but don't treat dementia. Lifestyle factors (exercise, social engagement, cognitive stimulation, cardiovascular risk management) have strong evidence.

Curcumin (B-grade): Anti-inflammatory (↓NF-κB, ↓COX-2), antioxidant, may reduce amyloid aggregation. RCT with Theracurmin: improved memory and mood, reduced amyloid and tau deposition on PET in older adults (PMID: 29246725). Systematic review: potential cognitive benefits (PMID: 27867087). Use bioavailable forms. 400-800mg daily.
Omega-3 Fatty Acids (DHA) (B-grade): DHA comprises 40% of brain polyunsaturated fatty acids; essential for membrane fluidity, synaptic plasticity. Meta-analysis: higher omega-3 associated with reduced cognitive decline (PMID: 26890759). Systematic review: DHA may benefit memory in ARCD (PMID: 22305186). Higher DHA formulations may be preferable for brain. 1-2g DHA daily.
Ginkgo Biloba (B-grade): Improves cerebral blood flow, antioxidant flavonoids, may modulate neurotransmitters. Meta-analysis: improves cognitive function in dementia and cognitive impairment (PMID: 27612937). EGb 761 is standardized extract used in most trials. 120-240mg daily in divided doses. Caution with anticoagulants.
CDP-Choline (Citicoline) (B-grade): Provides choline for acetylcholine synthesis and cytidine for nucleotide synthesis. Supports phosphatidylcholine (membrane component). Systematic review: improves memory and attention in cognitive impairment (PMID: 25072733). 500-1000mg daily.
Phosphatidylserine (C-grade): Membrane phospholipid that decreases with age; affects signal transduction, neurotransmitter release. Meta-analysis: may improve memory and cognitive function, particularly in elderly (PMID: 21103034). FDA allows qualified health claim. 100-300mg daily.
Vitamin D (B-grade): VDR in hippocampus and cortex; affects neurotrophic factors, neuroinflammation. Meta-analysis: low vitamin D associated with cognitive decline and dementia risk (PMID: 29684919). Supplementation may slow decline in deficient individuals. Target 40-60 ng/mL. 2000-4000 IU daily.
B Vitamins (B-grade): Reduce homocysteine (neurotoxic, vascular damage). Systematic review: B vitamins may slow cognitive decline (PMID: 22205419). VITACOG RCT: B vitamins (B6, B12, folic acid) slowed brain atrophy by 30% in MCI patients with elevated homocysteine (PMID: 20838622). Effects strongest with elevated homocysteine. Check B12, homocysteine. Use methylated forms.
Bacopa Monnieri (B-grade): Bacosides enhance cholinergic function, have antioxidant effects, increase dendritic branching. Meta-analysis: improves attention, cognitive processing, memory (PMID: 24252493). 300-600mg standardized to 50% bacosides. Takes 8-12 weeks for full effect.
Polygala Tenuifolia (C-grade): Contains tenuifolin, polygalasaponins with nootropic effects. Review: traditional use for memory; preclinical evidence for neuroprotection, may enhance neuroplasticity (PMID: 28539101). Limited clinical trial data. 100-300mg extract daily.

Biomarker targets: Cognitive testing (MoCA, MMSE for screening; detailed neuropsychological testing if indicated), vitamin B12, homocysteine (<10 μmol/L), 25(OH)D (>40 ng/mL), thyroid function, basic metabolic panel, lipid profile, HbA1c.

Protocol notes: Physical exercise has strongest evidence for maintaining cognitive function—150 min/week moderate aerobic activity increases hippocampal volume and BDNF. Social engagement protects against decline. Cognitive stimulation (learning new skills, reading, puzzles) builds cognitive reserve. Mediterranean/MIND diet associated with lower dementia risk. Cardiovascular risk factor management critical—what's good for the heart is good for the brain. Treat sleep apnea (common, treatable cause of cognitive issues). Address hearing loss (associated with cognitive decline). Manage depression and anxiety. Moderate alcohol (or abstain). Avoid anticholinergic medications. Adequate sleep (7-8 hours). Stress management. Review medications that affect cognition. Regular cognitive screening in elderly. Distinguish normal aging from MCI from dementia for appropriate management.